REFERENCES
- Blanco I, Canto H, de Serres FJ, Fernandez-Bustillo E, Rodriguez MC: Alpha 1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha 1-antitrypsin deficiency. J Rheumatol 31(10): 2082–2085, 2004.
- Blanco I, de Serres FJ, Bustillo EF, Al Kassam D, Arbesú D, Rodríguez C, : Alpha 1-Antitrypsin and fibromyalgia: New data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses (Oxford) 64: 759–769, 2005.
- Blanco I, Janciauskiene S, Astudillo A, Domínguez F, Bustillo EF, Nita I: Fibromyalgia and alpha-1 antitrypsin, chapter 1. New Research in Fibromyalgia. Nova Science Publisher, New York, 2006.
- Blanco I, Arbesú D, Al Kassam D, de Serres F, Fernández-Bustillo E, Rodríguez Menéndez C: Alpha 1-antitrypsin polymorphism in fibromyalgia patients from the Asturias Province in Northern Spain: A significantly higher prevalence of the PI*Z deficiency allele in patients than in the general population. J Musculoske Pain 14(3): 5–12, 2006.
- Russell IJ: Alpha 1-antitrypsin deficiency in the fibromyalgia syndrome. J Musculoske Pain 14(3): 1–3, 2006.
- Blanco I, De Serres FJ, Janciauskiene S, Arbesú D, Bustillo EF, Cárcaba V, : Estimates of the prevalence and number of fibromyalgia syndrome patients and their alpha-1 antitrypsin phenotypic distribution in ten countries. J Musculoske Pain 15(4): 9–23, 2007.
- Russell IJ: Pathogenesis of the fibromyalgia syndrome. J Musculoske Pain 15(4): 5–8, 2007.
- Aldonyte R, Jansson L, Ljungberg O, Larsson S, Janciauskiene S: Polymerized alpha-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of alpha-antitrypsin polymerization. Histopathology 45(6): 587–592, 2004.
- Janciauskiene S, Stevens T, Blanco I: New insights into the biology of alpha 1-antitrypsin and its role in chronic obstructive pulmonary disease. Curr Respir Med Rev 3: 147–158, 2007.
- Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, : Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7(7): 821–826, 2001.
- Vergnolle N: Modulation of visceral pain and inflammation by protease-activated receptors. Br J Pharmacol 141(8): 1264–1274, 2004.
- Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Blaber M, : Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol Chem 387(6): 817–824, 2006.